People with lupus, an autoimmune disease, suffer from fatigue, joint pain and swelling and also have a markedly increased risk of developing osteoporosis. Clinical trials have shown that receiving a transplant of mesenchymal stem cells can greatly improve the condition of lupus patients, yet it has not been clear why this treatment strategy works so well.
Family Risk of Breast Cancer Does Not Negatively Affect General Psychosocial Adjustment Among Pre-Teen Girls, Penn Study Finds
Penn Researchers Examine Effects of Federal Recommendations on Cartilage Repair Studies in Large Animal Models
More than 21 million people in the United States suffer from cartilage damage, and if left untreated, cartilage defects can cause disability and more widespread joint disease. In recent years, scientists have focused on development of new treatments for cartilage repair.
Epilepsy affects more than 65 million people worldwide. One-third of these patients have seizures that are not controlled by medications. In addition, one-third have brain lesions, the hallmark of the disease, which cannot be located by conventional imaging methods.
Kate Davis and Ravinder Reddy of the Perelman School of Medicine are quoted about a new imaging technique in development to treat epilepsy patients.
More and more, scientists have realized that DNA is not the only way that a parent can pass on traits to their offspring. Events experienced by a parent over a lifetime can also have an impact.
Katharyn Hanson stands on stage at the World Café Live in Philadelphia in front of a crowd of several dozen. Behind her flash images of antiquities and artifacts that make up much of the cultural legacy in places like Syria and Iraq. Sprinkled throughout are photos of explosions, dark gray plumes masking former heritage sites.
Turncoat Protein Regulates Sensitivity of Breast Cancer Cells to Drug, Providing New Target for Preventing Relapses, Finds Penn Study
Penn Team Maps First Comprehensive Profile of Non-Protein-Coding RNAs to Provide Clinicians with New Way to Diagnose Array of Cancers
Growing insights about a significant, yet poorly understood, part of the genome – the “dark matter of DNA” -- have fundamentally changed the way scientists approach the study of diseases.